Drugs / cannabidiol extract
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04280289 | Feb → Dec 2021 | epilepsy | University of Mississippi, Oxford | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cannabidiol extract | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04280289 ↗ |
| Known as | CBDE | “after a single dose of CBDE (cannabidiol extract), although the plan is to extend these studies to multiple dose administrations in the future” NCT04280289 ↗ |
| Route | Oral | “CBD Cannabis Extract Oral Solution” NCT04280289 ↗ |